The company says it “delivers prescription strength without a prescription.”

Increased nuclear factor kappa-B in rosacea may be a key to future therapies.

This therapy helps improve tear stability, meibum expression and corneal epithelial damage scores after one month.

New system better stratifies patients by primary tumor features and outcomes.

With many treatments available, the easiest solution may literally be rose-colored glasses.

Research suggests KCN patients may be prone to lid-related signs and symptoms.

This unique procedure may help alleviate dry eye sequelae.